On behalf of the Management Boards of the Pelion Healthcare Group companies, I present to you the report discussing our performance in 2014.
The Pelion Group's strategy is to build a strong position in the pharmaceutical segment of the European healthcare market and to create sustainable value on the capital market.
In 2014, the value of pharmacy sales reached PLN 28,496m (up 2.7% year on year), the value of wholesaler-to-pharmacy sales was PLN 25,229m (up 5.1% year on year), and the value of drugs sold to hospital pharmacies stood at PLN 4,343m (up 14.7% year on year). The value of wholesaler-to- pharmacy market in Lithuania reached LTL 1,646m (up 2.6% year on year)
In 2014, the Group delivered revenue of PLN 7,698.8m, which represented a 5.1% growth year on year. The Pelion Group was among TOP3 wholesalers to pharmacies and held leadership position in hospital supplies and retail sales in Poland. It was also the one of the leading pharmaceutical wholesaler in Lithuania, and its share in retail sales was 22% (adding partner pharmacies the share was 34%, which resulted in the first position on the Lithuanian market).
Pelion is a company responsible to all its stakeholders, among which the employees are a particular group. The overarching objective of the Pelion Healthcare Group's HR Policy, adopted for years 2013-2015, is to recruit and retain a team of employees who, in pursuit of the Company's mission and targets, will build its market value and sustainable competitive advantage, and at the same time achieve job satisfaction and fulfil their personal plans and ambitions.
In 2014, the Company complied with corporate governance principles for listed companies,
as specified in appendix to Resolution No. 19/1307/2012 of the WSE Supervisory Board,
dated November 21st 2012: 'Code of Best Practice for WSE Listed Companies'. The text of
the Code is available on the WSE’s website dedicated to corporate governance: (www.corp-gov.gpw.pl) and on the Company’s website
(http://pelion.eu/en/good_practices.html).
total share in shareholder structure 25.74% and share in total votes at GM 54.05%
* KIPF Sp. z o.o – a company in which Jacek Szwajcowski and Zbigniew Molenda are shareholders
Shareholders holding over 5% of total vote at GM (as of 31st December 2014):
Jacek Szwajcowski - Founder of Pelion S.A., President of the Management Board since the Company’s inception
Zbigniew Molenda - Founder of Pelion S.A., Vice-President of the Management Board since the Company’s inception
KIPF Sp. z o.o. - Subsidiary undertaking of Jacek Szwajcowski and Zbigniew Molenda who are its shareholders
AVIA OFE AVIVA BZ WBK - One of the leading pension funds in Poland
ING OFE - One of the leading pension funds in Poland
LEGG MASON - Entity within Legg Mason Group, one of the leading asset management fund all over the world
FMR LCC - Entity within Fidelity Investments Group, one of the leading investing fund all over the world
Awards and distinctions received by the Pelion Healthcare Group are a proof of the highest quality of our operations and our commitment to corporate social responsibility initiatives.
The Pelion Healthcare Group's Annual Report is the Group's third consecutive report discussing activities, financial results and corporate social responsibility in a comprehensive manner. The CSR data were integrated with other sections of the annual report to present a broad picture of how the Group companies manage their social impacts and build their value.
